Multi-phase, patient navigator-based program in the Richmond and Tidewater regions of Virginia to demonstrate: 1. the feasibility of using patient navigators to improve the percentage of children and adult (age 15 and older) patients with sickle cell disease (SCD) in SCD specialty care 2. the efficacy of using patient navigators to improve hydroxyurea (HU) (re-)initiation and adherence among adult patients with SCD eligible for HU (Patient navigators may also be known as public health workers.)
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Phase I: Percent of enrolled Phase I subjects who complete a provider visit by 3 months post enrollment
Timeframe: 3 months
Phase II: Increase in fetal hemoglobin (HbF) as measured by hemoglobin electrophoresis
Timeframe: Baseline, 6 months, 1 year